Cancer Research Targets  Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurinna, S. M.
Right arrow Articles by Ruvolo, P. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurinna, S. M.
Right arrow Articles by Ruvolo, P. P.
[Cancer Research 64, 7852-7856, November 1, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Ceramide Promotes Apoptosis in Lung Cancer-Derived A549 Cells by a Mechanism Involving c-Jun NH2-Terminal Kinase

Svitlana M. Kurinna1, Chun Chui Tsao1, Alina Felicia Nica1,2, Tilahun Jiffar1 and Peter P. Ruvolo1,2

1 Division of Cell Signaling, Institute of Molecular Medicine, University of Texas Health Science Center, and 2 University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas

Ceramide regulates diverse signaling pathways involving cell senescence, the cell cycle, and apoptosis. Ceramide is known to potently activate a number of stress-regulated enzymes, including the c-Jun NH2-terminal kinase (JNK). Although ceramide promotes apoptosis in human lung cancer-derived A549 cells, a role for JNK in this process is unknown. Here, we report that ceramide promotes apoptosis in A549 cells by a mechanism involving JNK. The JNK inhibitor SP600125 proved effective at protecting cells from the lethal effects of ceramide. To understand which JNK-mediated pathway may be involved, a number of JNK target proteins were examined, including the transcription factor, c-Jun, and the apoptotic regulatory proteins Bcl-XL and Bim. A549 cells exhibited basal levels of phosphorylated c-Jun in nuclear fractions, revealing that active c-Jun is present in these cells. Ceramide was found to inhibit c-Jun phosphorylation, suggesting that JNK-mediated phosphorylation of c-Jun is not likely involved in ceramide-induced apoptosis. Ceramide did not promote Bcl-XL phosphorylation. On the other hand, ceramide promoted phosphorylation of Bim and induced translocation of active JNK from the nucleus to the cytoplasm and mitochondrial fraction. Ceramide-mediated changes in localization of JNK were consistent with the observed changes in phosphorylation status of c-Jun and Bim. Furthermore, ceramide promoted Bim translocation to the mitochondria. Mitochondrial localization of Bim has been shown recently to promote apoptosis. These results suggest that JNK may participate in ceramide-induced apoptosis in A549 cells by a mechanism involving Bim.




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. Zhang, O. Kamdar, W. Le, G. D. Rosen, and D. Upadhyay
Nicotine Induces Resistance to Chemotherapy by Modulating Mitochondrial Signaling in Lung Cancer
Am. J. Respir. Cell Mol. Biol., February 1, 2009; 40(2): 135 - 146.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Pattingre, C. Bauvy, S. Carpentier, T. Levade, B. Levine, and P. Codogno
Role of JNK1-dependent Bcl-2 Phosphorylation in Ceramide-induced Macroautophagy
J. Biol. Chem., January 30, 2009; 284(5): 2719 - 2728.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
S. Ghose, N. V. Oleinik, N. I. Krupenko, and S. A. Krupenko
10-Formyltetrahydrofolate Dehydrogenase-Induced c-Jun-NH2-Kinase Pathways Diverge at the c-Jun-NH2-Kinase Substrate Level in Cells with Different p53 Status
Mol. Cancer Res., January 1, 2009; 7(1): 99 - 107.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C.-L. Chen, C.-F. Lin, W.-T. Chang, W.-C. Huang, C.-F. Teng, and Y.-S. Lin
Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway
Blood, April 15, 2008; 111(8): 4365 - 4374.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. G. Roberts, E. Gurisik, T. J. Biden, R. L. Sutherland, and A. J. Butt
Synergistic cytotoxicity between tamoxifen and the plant toxin persin in human breast cancer cells is dependent on Bim expression and mediated by modulation of ceramide metabolism
Mol. Cancer Ther., October 1, 2007; 6(10): 2777 - 2785.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Kroemer, L. Galluzzi, and C. Brenner
Mitochondrial Membrane Permeabilization in Cell Death
Physiol Rev, January 1, 2007; 87(1): 99 - 163.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Kitatani, J. Idkowiak-Baldys, J. Bielawski, T. A. Taha, R. W. Jenkins, C. E. Senkal, B. Ogretmen, L. M. Obeid, and Y. A. Hannun
Protein Kinase C-induced Activation of a Ceramide/Protein Phosphatase 1 Pathway Leading to Dephosphorylation of p38 MAPK
J. Biol. Chem., December 1, 2006; 281(48): 36793 - 36802.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
V E MacRae, T Burdon, S F Ahmed, and C Farquharson
Ceramide inhibition of chondrocyte proliferation and bone growth is IGF-I independent.
J. Endocrinol., November 1, 2006; 191(2): 369 - 377.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Y. Wei, D. Wang, F. Topczewski, and M. J. Pagliassotti
Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells
Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E275 - E281.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Carlo-Stella, M. Di Nicola, M. C. Turco, L. Cleris, C. Lavazza, P. Longoni, M. Milanesi, M. Magni, M. Ammirante, A. Leone, et al.
The Anti-Human Leukocyte Antigen-DR Monoclonal Antibody 1D09C3 Activates the Mitochondrial Cell Death Pathway and Exerts a Potent Antitumor Activity in Lymphoma-Bearing Nonobese Diabetic/Severe Combined Immunodeficient Mice
Cancer Res., February 1, 2006; 66(3): 1799 - 1808.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.